Skip to main content
. 2019 Sep 5;69(Suppl 2):S72–S80. doi: 10.1093/cid/ciz462

Table 1.

Hospitalizations for Pneumonia and Meningitis Pre– and Post–13-Valent Pneumococcal Conjugate Vaccine Introduction, per Month, 2010–2016

Age Group, months Time Period Pneumonia, n (%) Pneumonia CFR, % Meningitis, n (%) Meningitis, CFR, % Total Hospitalizations
0–11 Pre-PCV13 (January 2010–June 2012) 145 (16) 12 9 (1) 25 904
Post-PCV13 (July 2013–December 2016) 102 (12) 8 8 (0.5) 16 859
12–59 Pre-PCV13 (January 2010–June 2012) 81 (19) 7 5 (1) 21 433
Post-PCV13 (July 2013–December 2016) 66 (14) 4 2 (0.5) 20 465

Abbreviations: CFR, case fatality ratio; PCV13, 13-valent pneumococcal conjugate vaccine.